About
Prevail Therapeutics is a clinical-stage gene therapy company focused on developing treatments for neurodegenerative diseases by targeting genetic mechanisms to address root causes.
Explore Prevail Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.